DocBlog enters its 3rd year
I am surprised myself – but DocBlog will be entering its 3rd year in January 2017. DocBlog was meant to address and comment on the everyday questions and problems that are brought to a doctor
Continue readingYear: 2016
What is actually the MSFC?
The abbreviation MSFC stands for the so-called Multiple Sclerosis Functional Composite Index. This is a quantitative examination, in which the 7.6m walking distance, the so-called 9-hole pegboard test and the PASAT3 test, a neurocognitive test,
Continue reading
Neuroborreliosis
In Germany, there is a diffuse fear of (Neuro)Lyme disease, a disease transmitted by the bacterium Borrelia burgdorferi, which lives in the digestive tract of ticks. Lyme disease is considered a “mysterious” disease, supposedly responsible
Continue reading
“Little Grey Cloud…”
I recently had the pleasure of attending the Ursula Späth Foundation’s AMSEL award ceremony – a truly beautiful and emotional event. This year’s media award went to filmmaker Sabine Marina for her film “Little Grey
Continue reading
News from ECTRIMS 2016 – Poster Sessions
In addition to traditional lectures and symposia, poster sessions are a key component of scientific congresses. For someone not familiar with the scientific world, the term “poster session” might sound a bit strange – but
Continue reading
News from ECTRIMS 2016 – Vitamin D
Many have been waiting for this – the results of the SOLAR study, a phase II study that investigated the effect of high-dose vitamin D as an add-on to immunomodulatory therapy with interferon-beta 1a s.c.
Continue reading News from ECTRIMS 2016 – Therapy options for progressive MS
Things are happening. After many years of no real therapeutic options for chronic progressive Multiple Sclerosis and many therapy studies have been negative, two substances have now actually shown significant effects on disability progression in
Continue reading News from ECTRIMS 2016 – Personalized MS Therapy
Last week, the 32nd Congress of the European Committee of Research and Treatment in Multiple Sclerosis (ECTRIMS) took place in London. ECTRIMS is exclusively concerned with multiple sclerosis and related diseases, making it by far
Continue readingIntrathecal Cortisone Therapy
Cortisone is used in the treatment of acute MS relapses in Multiple Sclerosis. Usually, a high-dose cortisone preparation is administered intravenously over a period of 3 to 5 days. In addition, high-dose intravenous cortisone administration
Continue readingDo I have MS…?!
I suspect that some people read my blog who do not have MS, but are afraid of getting MS. In such a situation, sites like DocBlog are used to learn about MS. Therefore, I want
Continue reading
